"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether "red morphine drops" applied in the mouth are
superior to an equivalent amount of morphine applied as subcutaneous injection for the relief
of breathlessness in terminal patients suffering from primary lung cancer or lung metastases.